February 27th 2013
Leonard G. Gomella, MD, discusses the benefits of the multidisciplinary center at Jefferson Kimmel Cancer Center.
May 30th 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on the Unique Attributes of Neoadjuvant Zytiga.
May 22nd 2012
Dr. Leonard Gomella, form the Jefferson Kimmel Cancer Center, on the Impact of the New USPSTF PSA Rating.
May 21st 2012
Dr. Leonard Gomella, from the Jefferson Kimmel Cancer Center, on the Provenge IMPACT Trial Survival Benefit
May 16th 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on Neoadjuvant Hormonal Therapy Combined With Abiraterone Acetate
May 1st 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, Discusses PSA Velocity
April 20th 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, Examines the Understating of Provenge Benefits
April 16th 2012
Dr. Leonard Gomella, from the Jefferson Kimmel Cancer Center, on Helping Patients Make Informed Medical Decisions
April 5th 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, Discusses the Challenges of PSA Screening
March 1st 2012
Dr. Leonard Gomella from the Jefferson Kimmel Cancer Center on the Cost of the Immunotherapy Sipuleucel-T
February 15th 2012
Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, Discusses the NeoACT Sipuleucel-T Study
January 9th 2012
Dr. Leonard Gomella, from Kimmel Cancer Center, Discusses Androgen-Deprivation Therapy
April 18th 2011
Dr. Leonard Gomella from the Jefferson Kimmel Cancer Center on Novel Prostate Cancer Immunotherapies
April 6th 2011
March 31st 2011
March 30th 2011
In an interview at the 2011 IPCC Meeting in New York, Leonard G. Gomella, MD, from Jefferson Kimmel Cancer Center, discusses prostate cancer screening procedures.